NANJING, China, Dec. 7, 2023 /PRNewswire/ The rapid advancement of technology has propelled the field of life sciences into unprecedented growth, constantly expanding our understanding and imagination. Particularly in the field of cellular gene therapy, a series of recent positive developments have been overwhelming. Recently, the world's first CRISPR/Cas9 gene editing therapy received market approval in the UK..
Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) saw a significant drop in short interest in November. As of November 15th, there was short interest totalling 4,376,100 shares, a drop of 7.4% from the October 31st total of 4,726,000 shares. Based on an average daily volume of 61,000 shares, the days-to-cover ratio is currently 71.7 […]
BioSpace s Best Places to Work report celebrates the top 30 small and large biopharma employers across America, and demonstrates a company s desirability in the recruitment marketplace, based on the.
Baculovirus Expression System Market Size Worth US$ 660 7 Million Globally with an Outstanding CAGR of 8 7% by 2030 | Coherent Market Insights | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
Viral Vector Development MarketOver the evaluation period from 2023 to 2033, the global viral vector development market is predicted to grow at a remarkable CAGR of 18.7%. By the end of 2023, the global market is anticipated to be valued at US$ 730.7 million, rising to US$ 4.1 billion by 2033. The historical study s.